Risedronate Sodium

×

Overview

What is Risedronate Sodium?

Risedronate sodium tablets, USP are a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each risedronate sodium tablet for oral administration contains the equivalent of 5 mg, 30 mg, 35 mg or 150 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate. The molecular formula for risedronate sodium hemi-pentahydrate is CHNOPNa • 2.5 HO. The chemical name of risedronate sodium is Sodium trihydrogen [1-hydroxy-2-(3-pyridyl)ethylidene] diphosphonate. The chemical structure of risedronate sodium hemi-pentahydrate is the following:

Risedronate sodium, USP is a fine, white to off-white, odorless, crystalline powder. It is soluble in water and in aqueous solutions, and essentially insoluble in common organic solvents.

Inactive Ingredients:

What does Risedronate Sodium look like?

What are the available doses of Risedronate Sodium?

Tablets: 5 mg, 30 mg, 35 mg and 150 mg ()

What should I talk to my health care provider before I take Risedronate Sodium?

Risedronate is not recommended for use in patients with severe renal impairment (creatinine clearance less than 30 mL/min) (, , )

Risedronate is not indicated for use in pediatric patients ()

How should I use Risedronate Sodium?

Risedronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. In postmenopausal women with osteoporosis, risedronate reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [].

[]

The recommended regimen is:

What interacts with Risedronate Sodium?

Sorry No Records found

What are the warnings of Risedronate Sodium?

Sorry No Records found

What are the precautions of Risedronate Sodium?

Sorry No Records found

What are the side effects of Risedronate Sodium?

Sorry No records found

What should I look out for while using Risedronate Sodium?

Risedronate sodium tablets are contraindicated in patients with the following conditions:

What might happen if I take too much Risedronate Sodium?

Decreases in serum calcium and phosphorus following substantial overdose may be expected in some patients. Signs and symptoms of hypocalcemia may also occur in some of these patients. Milk or antacids containing calcium should be given to bind risedronate and reduce absorption of the drug.

In cases of substantial overdose, gastric lavage may be considered to remove unabsorbed drug. Standard procedures that are effective for treating hypocalcemia, including the administration of calcium intravenously, would be expected to restore physiologic amounts of ionized calcium and to relieve signs and symptoms of hypocalcemia.

Lethality after single oral doses was seen in female rats at 903 mg/kg and male rats at 1703 mg/kg. The minimum lethal dose in mice and rabbits was 4000 mg/kg and 1000 mg/kg, respectively. These values represent 320 to 620 times the 30 mg human dose based on surface area (mg/m).

How should I store and handle Risedronate Sodium?

Topiramate extended-release capsules should be stored in well-closed containers at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Protect from moisture and light.Topiramate extended-release capsules should be stored in well-closed containers at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].Protect from moisture and light.Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:Risedronate Sodium Tablets, USP are available containing 5 mg, 30 mg, 35 mg or 150 mg risedronate sodium, USP.The 5 mg tablets are light beige, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4044-93bottles of 30 tabletsNDC 0378-4044-05bottles of 500 tabletsThe 30 mg tablets are white, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4114-93bottles of 30 tabletsNDC 0378-4114-05bottles of 500 tabletsThe 35 mg tablets are light orange, film-coated, round, unscored tablets debossed with on one side of the tablet and on the other side. They are available as follows:NDC 0378-4714-99unit of use blister card containing 4 tabletsNDC 0378-4714-92carton of 10 cards each containing 4 tabletsNDC 0378-4714-96unit of use blister card containing 12 tabletsNDC 0378-4714-78carton of 10 cards each containing 12 tabletsThe 150 mg tablets are light blue, film-coated, round, unscored tablets debossed with over on one side of the tablet and on the other side. They are available as follows:NDC 0378-4150-32unit of use blister card containing 1 tabletNDC 0378-4150-97carton of 10 cards each containing 1 tabletNDC 0378-4150-53unit of use blister card containing 3 tabletsNDC 0378-4150-93carton of 10 cards each containing 3 tabletsStore at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.PHARMACIST:

×

Clinical Information

Chemical Structure

No Image found

Clinical Pharmacology

Risedronate has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent. At the cellular level, risedronate inhibits osteoclasts. The osteoclasts adhere normally to the bone surface, but show evidence of reduced active resorption (for example, lack of ruffled border). Histomorphometry in rats, dogs, and minipigs showed that risedronate treatment reduces bone turnover (activation frequency, that is, the rate at which bone remodeling sites are activated) and bone resorption at remodeling sites.

Non-Clinical Toxicology

Risedronate sodium tablets are contraindicated in patients with the following conditions:

Prior administration of succinylcholine may enhance the neuromuscular blocking effect of vecuronium and its duration of action. If succinylcholine is used before vecuronium, the administration of vecuronium should be delayed until the succinylcholine effect shows signs of wearing off. With succinylcholine as the intubating agent, initial doses of 0.04 to 0.06 mg/kg of vecuronium may be administered to produce complete neuromuscular block with clinical duration of action of 25 to 30 minutes (see ).

The use of vecuronium before succinylcholine, in order to attenuate some of the side effects of succinylcholine, has not been sufficiently studied.

Other nondepolarizing neuromuscular blocking agents (pancuronium, d-tubocurarine, metocurine, and gallamine) act in the same fashion as does vecuronium; therefore, these drugs and vecuronium, may manifest an additive effect when used together. There are insufficient data to support concomitant use of vecuronium and other competitive muscle relaxants in the same patient.

Risedronate sodium tablets contain the same active ingredient found in Atelvia. A patient being treated with Atelvia should not receive risedronate sodium tablets.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Disclaimer: